Dr. Benjamin H. Levy III, M.D.
Gastroenterology (Gastroenterology Physician)
1401 S California Ave, Schwab Adult Medicine
Chicago, IL 60608
Who else practices at this address →
Cook County includes primary care (3% of residents) and mental health (4% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Emory University School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 248
Licensed in Illinois since 2014, according to the Illinois Department of Financial and Professional Regulation. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2008Medical school: Emory University School of Medicine
- 2009Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
IL license 036135555 (first issued 2014; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The University of Chicago Medical Center Chicago, IL
- Ingalls Memorial Hospital Harvey, IL
Medical groups
- University of Chicago (1,712 clinicians)
- The University of Chicago Medical Center (915 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 248
- Services billed
- 484
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 121 | 79 |
| Biopsy of large bowel using a flexible endoscope | 64 | 64 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 48 | 48 |
| New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | 42 |
| New patient office or other outpatient visit, 60-74 minutes | 20 | 20 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 18 | 18 |
| Insertion of needle into vein for collection of blood sample | 12 | 12 |
| Established patient office or other outpatient visit, 30-39 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Pantoprazole Sodium Other prescribers in Chicago, IL | 256 |
| Linzess (linaclotide) Other prescribers in Chicago, IL | 89 |
| Omeprazole Other prescribers in Chicago, IL | 83 |
| Dicyclomine Hcl Other prescribers in Chicago, IL | 76 |
| Famotidine Other prescribers in Chicago, IL | 47 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Chicago, IL | 28 |
| Gavilyte-G (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Chicago, IL | 23 |
| Creon (lipase/protease/amylase) Other prescribers in Chicago, IL | 23 |
| Peg-3350 And Electrolytes (peg3350/sod sulf,bicarb,cl/kcl) Other prescribers in Chicago, IL | 19 |
| Esomeprazole Magnesium Other prescribers in Chicago, IL | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 8 payments worth $841 in total to this clinician.
| Janssen Biotech, Inc. | $285 |
|---|---|
| Janssen Scientific Affairs, LLC | $150 |
| Ardelyx, Inc. | $139 |
| Phathom Pharmaceuticals, Inc. | $104 |
| Exact Sciences Corporation | $92.93 |
| Laborie Medical Technologies Corp. | $69.86 |
| Food and Beverage | $841 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $132,280 in research payments for these studies, mostly to the institutions running them.
- Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
Daiichi Sankyo Inc. · Active, not recruiting · NCT05215340 - Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)
Daiichi Sankyo Inc. · Active, not recruiting · NCT04526691
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.